Bookbuilding IPO | ₹410 Cr | Listed at NSE, BSE | Mon, Jan 6, 2025 - Wed, Jan 8, 2025
Standard Glass Lining IPO is a book build issue of ₹410.05 crores. The issue is a combination of fresh issue of 1.50 crore shares aggregating to ₹210.00 crores and offer for sale of 1.43 crore shares aggregating to ₹200.05 crores.
Standard Glass Lining IPO bidding started from Jan 6, 2025 and ended on Jan 8, 2025. The allotment for Standard Glass Lining IPO was finalized on Jan 9, 2025. The shares got listed on NSE, BSE on Jan 13, 2025.
Standard Glass Lining IPO price band is set at ₹140 per share. The lot size for an application is 107. The minimum amount of investment required by an retail is ₹14,980 (107 shares) (based on upper price). The lot size investment for sNII is 14 lots (1,498 shares), amounting to ₹2,09,720, and for bNII, it is 67 lots (7,169 shares), amounting to ₹10,03,660.
IIFL Capital Services Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Standard Glass Lining IPO RHP for detailed Information.
IPO Open
Mon, Jan 6, 2025
IPO Close
Wed, Jan 8, 2025
Issue Price
₹140 per share
Market Cap (Pre-IPO)
₹2,792.88 Cr
| IPO Date | 6 to 8 Jan, 2025 |
| Listed on | Mon, Jan 13, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹133 to ₹140 |
| Issue Price | ₹140 per share |
| Lot Size | 107 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE, BSE |
| Total Issue Size | 2,92,89,367 shares (agg. up to ₹410 Cr) |
| Fresh Issue | 1,50,00,000 shares (agg. up to ₹210 Cr) |
| Offer for Sale | 1,42,89,367 shares of ₹10 (agg. up to ₹200 Cr) |
| Share Holding Pre Issue | 18,44,91,662 shares |
| Share Holding Post Issue | 19,94,91,662 shares |
| 544333 SGLTL | |
| ISIN | INE0M4D01010 |
Standard Glass Lining IPO offers total 2,92,88,569 shares. Out of which 1,46,43,884 (50.00%) allocated to QIB, 58,57,875 (20.00%) allocated to QIB (Ex- Anchor), 43,93,406 (15.00%) allocated to NII 1,02,51,279 (35.00%) allocated to RII and 87,86,009 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Max Allottees |
|---|---|---|
| QIB Shares Offered | 1,46,43,884 (50.00%) | NA |
| − Anchor Investor Shares Offered | 87,86,009 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 58,57,875 (20.00%) | NA |
| NII (HNI) Shares Offered | 43,93,406 (15.00%) | NA |
| − bNII > ₹10L | 29,28,937 (10.00%) | 1,955 |
| − sNII < ₹10L | 14,64,469 (5.00%) | 977 |
| Retail Shares Offered | 1,02,51,279 (35.00%) | 95,806 |
| Total Shares Offered | 2,92,88,569 (100.00%) |
Investors can bid for a minimum of 107 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 107 | ₹14,980 |
| Retail (Max) | 13 | 1,391 | ₹1,94,740 |
| S-HNI (Min) | 14 | 1,498 | ₹2,09,720 |
| S-HNI (Max) | 66 | 7,062 | ₹9,88,680 |
| B-HNI (Min) | 67 | 7,169 | ₹10,03,660 |
Standard Glass Lining IPO raises ₹123.00 crore from anchor investors. Standard Glass Lining IPO Anchor bid date is January 3, 2025.
📝 Anchor Investors Letter (PDF)
| Bid Date | Fri, Jan 3, 2025 |
| Shares Offered | 87,86,009 |
| Anchor Portion (₹ Cr.) | 123.00 |
| Anchor lock-in period end date for 50% shares (30 Days) | Fri, Feb 7, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | Tue, Apr 8, 2025 |
Incorporated in September 2012, Standard Glass Lining Technology Limited is a manufacturer of engineering equipment for the pharmaceutical and chemical sectors in India. The company has the capability to manage the entire production process in-house.
The company provides turnkey solutions, including design, engineering, manufacturing, assembly, installation, and standard operating procedures for pharmaceutical and chemical manufacturers.
The company's product product portfolio includes
The company manufactures specialized engineering equipment using glass-lined materials, stainless steel, and nickel alloy.
The company's customer includes Apitoria Pharma Private Limited, Aurobindo Pharma Limited, CCL Food and Beverages Private Limited, Cohance Lifesciences Limited, Cadila Pharmaceutical Limited, Deccan Fine Chemicals (India) Private Limited, Dasami Lab Private Limited, Laurus Labs Limited, Granules India Limited, Macleods Pharmaceuticals Limited, MSN Laboratories Private Limited, Natco Pharma Limited, Honour Lab Limited, Hetero Drugs Limited, Hetero Labs Limited, Hazelo Lab Private Limited, Piramal Pharma Limited, Sanvira Biosciences Private Limited, Suven Pharmaceuticals Limited, Tagros Chemicals India Private Limited, Vamsi Labs Limited and Viyash Life Sciences Private Limited.
The company has eight manufacturing units situated in Hyderabad, Telangana.
The company's sales offices are situated in Vadodara, Gujarat, Ankleshwar, Gujarat, Mumbai, Maharashtra and Vishakhapatnam, Andhra Pradesh and sales team members are in Jhagadia, Gujarat, Chennai, Tamil Nadu, New Delhi, Bengaluru, Karnataka and Vijayawada, Andhra Pradesh with pan-India reach.
As of September 30, 2024, the company had 460 full-time employees and 731 contract labourers.
Competitive Strength
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 756.52 | 665.38 | 347.79 | 298.11 |
| Total Income | 312.10 | 549.68 | 500.08 | 241.50 |
| Profit After Tax | 36.27 | 60.01 | 53.42 | 25.15 |
| NET Worth | 447.80 | 409.92 | 156.67 | 69.91 |
| Reserves and Surplus | 261.58 | 389.18 | 139.94 | 53.66 |
| Total Borrowing | 173.80 | 129.32 | 81.96 | 69.81 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding of capital expenditure requirements of the Company towards purchase of machinery and equipment; | 10.00 |
| 2 | Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by our Company and investment in our wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by S2 Engineering Industry Private Limited, from banks and financial institutions | 130.00 |
| 3 | Investment in our wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for funding its capital expenditure requirements towards purchase of machinery and equipment | 30.00 |
| 4 | Funding inorganic growth through strategic investments and/or acquisitions; and | 20.00 |
| 5 | General corporate purposes. | 3.43 |
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 20.74% |
| ROCE | 25.49% |
| Debt/Equity | 0.32 |
| RoNW | 20.74% |
| PAT Margin | 10.92% |
| Price to Book Value | 5.70 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 3.25 | 3.64 |
| P/E (x) | 43.04 | 38.5 |
| Promoter Holding | 72.49% | 67.04% |
| Market Cap | ₹2,792.88 Cr. |
The Standard Glass Lining IPO is subscribed 185.48 times on January 8, 2025 6:19:08 PM (Day 3). The public issue subscribed 65.71 times in the retail category, 327.76 times in the QIB category, and 275.21 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 327.76 | 58,57,875 | 1,91,99,91,629 |
| NII | 275.21 | 43,93,405 | 1,20,91,09,951 |
| bNII (bids above ₹10L) | 302.21 | 29,28,937 | 88,51,48,512 |
| sNII (bids below ₹10L) | 221.21 | 14,64,468 | 32,39,61,439 |
| Retail | 65.71 | 1,02,51,278 | 67,36,54,452 |
| Total | 185.48 | 2,05,02,558 | 3,80,27,56,032 |
Total Application : 52,39,243
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | BRLMs fees and commissions | 13.54 |
| 2 | Selling commission/processing fee for SCSBs, Sponsor Banks and fee payable to the Sponsor Banks for Bids made by RIBs, brokerage and selling commission and bidding/uploading charges for members of the Syndicate (including their subSyndicate Members), Registered Brokers, RTAs and CDPs | 1.74 |
| 3 | Fees payable to the Registrar to the Offer | 1.35 |
| 4 | Listing fees, SEBI filing fees, upload fees, BSE and NSE processing fees, book building software fees and other regulatory expenses | 6.87 |
| 5 | Printing and stationery expenses | 0.80 |
| 6 | Advertising and marketing expenses | 1.68 |
| 7 | Fees payable to legal counsels and auditors | 3.79 |
| 8 | Miscellaneous | 2.59 |
| Price Details | NSE | BSE |
|---|---|---|
| Final Issue Price | ₹140.00 | ₹140.00 |
| Open | ₹172.00 | ₹176.00 |
| Low | ₹161.00 | ₹161.00 |
| High | ₹182.00 | ₹181.70 |
| Last Trade | ₹163.28 | ₹163.35 |
Lead Manager Reports
Standard Glass Lining IPO is a main-board IPO of 2,92,89,367 equity shares of the face value of ₹10 aggregating up to ₹410 Crores. The issue is priced at ₹140 per share. The minimum order quantity is 107.
The IPO opens on Mon, Jan 6, 2025, and closes on Wed, Jan 8, 2025.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE, BSE.
Zerodha customers can apply online in Standard Glass Lining IPO using UPI as a payment gateway. Zerodha customers can apply in Standard Glass Lining IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Standard Glass Lining IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Standard Glass Lining IPO opens on Mon, Jan 6, 2025 and closes on Wed, Jan 8, 2025.
Standard Glass Lining IPO lot size is 107, and the minimum amount required for application is ₹14,980.
You can apply in Standard Glass Lining IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Standard Glass Lining IPO will be done on Thursday, January 9, 2025, and the allotted shares will be credited to your demat account by Fri, Jan 10, 2025. Check the Standard Glass Lining IPO allotment status.
The Standard Glass Lining IPO listing date is on Mon, Jan 13, 2025.
